• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vet Res . Spray vaccination with a safe and bivalent H9N2 recombinant chimeric NDV vector vaccine elicits complete protection against NDV and H9N2 A

tetano

Editor, Senior Moderator
Vet Res


. 2025 Jan 31;56(1):24.
doi: 10.1186/s13567-025-01448-5. Spray vaccination with a safe and bivalent H9N2 recombinant chimeric NDV vector vaccine elicits complete protection against NDV and H9N2 AIV challenge

Xiaoquan Wang[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Jing Dai[SUP] #[/SUP][SUP] 1 [/SUP], Wenhao Yang[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Yao Yao[SUP] 1 [/SUP], Jin Zhang[SUP] 1 [/SUP], Kaituo Liu[SUP] 2 3 4 [/SUP], Xiaolong Lu[SUP] 1 2 3 [/SUP], Ruyi Gao[SUP] 1 2 3 [/SUP], Yu Chen[SUP] 1 2 3 [/SUP], Jiao Hu[SUP] 1 2 3 [/SUP], Min Gu[SUP] 1 2 3 [/SUP], Shunlin Hu[SUP] 1 2 3 [/SUP], Xiufan Liu[SUP] 5 6 7 [/SUP], Xiaowen Liu[SUP] 8 9 10 [/SUP]



Affiliations
Abstract

Newcastle disease virus (NDV) and H9N2 avian influenza virus (AIV) represent significant pathogenic risks to the poultry industry, leading to considerable economic losses. Vaccination is a widely used preventive measure against these pathogens, yet the lack of a live bivalent vaccine targeting NDV and H9N2 AIV imposes a heavy vaccination burden. Previously, we constructed a genotype-matched chimeric NDV vector, LX-OAI4S, in which the genotype I NDV backbone was replaced with the ectodomain of haemagglutinin-neuraminidase (HN) and modified using the attenuated F gene from the genotype VII vaccine strain A-VII. Based on the LX-OAI4S vector, we successfully generated three H9N2 recombinant viruses: LX-OAI4S-NPU-HA, LX-OAI4S-MU-HA, and LX-OAI4S-HNU-HA. These recombinants incorporated the H9N2 HA gene, flanked by untranslated regions (UTRs) from the NP, M, or HN gene of the NDV LX strain, inserted between the P and M genes of LX-OAI4S. The vaccine candidate LX-OAI4S-NPU-HA induced a more robust immune response in chickens against H9N2 AIV and NDV than the other two recombinants. This response effectively protects against virus shedding and lethal virus challenge. Furthermore, spray vaccination with LX-OAI4S-NPU-HA showed protective efficacy against H9N2 AIV and NDV. This study offers a promising strategy for comprehensive protection in regions threatened by H9N2 AIV and NDV.

Keywords: H9N2 subtype avian influenza virus; Newcastle disease virus; chicken; spray vaccination; vaccine.

 
Back
Top Bottom